Trial
NCT03066739
Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Irvine
Collaborators
—
Condition
Hyperalgesia
Intervention
Remifentanil
Why stopped
Study terminated early due to low enrollment. Only 8 participants enrolled out of the target 105.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04